Compare MDAIW & PSUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDAIW | PSUS |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2021 | 2023 |
| Metric | MDAIW | PSUS |
|---|---|---|
| Price | $0.59 | $36.82 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $43.00 |
| AVG Volume (30 Days) | 7.1K | ★ 288.0K |
| Earning Date | 02-27-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.88 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,650,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.36 | $35.71 |
| 52 Week High | $1.01 | $40.90 |
| Indicator | MDAIW | PSUS |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 38.76 |
| Support Level | $0.39 | $35.71 |
| Resistance Level | $0.58 | $39.59 |
| Average True Range (ATR) | 0.04 | 0.68 |
| MACD | -0.00 | -0.20 |
| Stochastic Oscillator | 18.21 | 19.66 |
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.
Pershing Square USA, Ltd. is a non-diversified, closed-end investment company. The Company'S investment objective is to preserve capital and seek maximum, long-term capital appreciation and growth in intrinsic value per share commensurate with reasonable risk, where risk is defined as the probability of permanent loss of capital, rather than price volatility. The investment objective is considered non-fundamental and may be changed by the Board without the approval of Common Shareholders. There can be no assurance that the Company's investment objective will be achieved.